News
The Sensex fell 721 points and the Nifty 50 dropped 225 points amid foreign fund withdrawals. Analysts predict upcoming ...
Bank of Baroda reported net profit at Rs 4,541 crore for Q1 FY26. This marks a 2 percent rise from the Rs 4,458 crore net ...
Cipla Ltd (BOM:500087) reports robust financial performance with significant milestones in India and strategic advancements in the US market.
Cipla, Chennai Petroleum Corporation, Prataap Snacks, Jammu & Kashmir Bank, Reliance Infrastructure, SBI Cards and Tata ...
Balkrishna Industries, Lodha Developers, Whirlpool, ZEN Technologies, and SBFC Finance are also to release their April-June ...
Total Income from operations rose to Rs 6,957 crore for the June quarter as compared with Rs 6,694 crore in the year-ago ...
Cipla consolidated net profit for the quarter ending June 2025 at ₹1291.61 crore was up 10% compared to ₹1175.46 crore in the ...
Porvorim: Blaming govt for doing little to ensure employment opportunities for locals, legislators on Friday said that ...
Indian pharmaceutical company, Cipla, aims to reach $1 billion in US sales by FY27, driven by upcoming product launches.
Cipla reported a 10% rise in Q1 PAT to ?1,298 crore, driven by India, Europe, and Africa sales. Revenue grew to ?6,957 crore despite a North America dip.
Cipla Health Ltd bagged the ‘Health & Wellness Company Of The Year’ award at the e4m Health & Wellness Marketing Awards 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results